Flurbiprofen is a type of nonsteroidal anti-inflammatory drug. Intravenous flurbiprofen was evaluated in patients with cancer for its effectiveness in relieving breakthrough pain. The administration of flurbiprofen in the perioperative period among women with breast cancer was evaluated for its potential effect on chronic pain after breast surgery.